Androski Lindsay bought ABUS

September 18, 2026 · Form 4 insider transaction

Androski Lindsay bought 10,456 shares of Arbutus Biopharma Corporation at $4.39 per share, a transaction worth $45.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.